These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
286 related items for PubMed ID: 11927169
1. Involvement of the sigma(1) receptor in cocaine-induced conditioned place preference: possible dependence on dopamine uptake blockade. Romieu P, Phan VL, Martin-Fardon R, Maurice T. Neuropsychopharmacology; 2002 Apr; 26(4):444-55. PubMed ID: 11927169 [Abstract] [Full Text] [Related]
2. Differential effects of sigma1 receptor blockade on self-administration and conditioned reinstatement motivated by cocaine vs natural reward. Martin-Fardon R, Maurice T, Aujla H, Bowen WD, Weiss F. Neuropsychopharmacology; 2007 Sep; 32(9):1967-73. PubMed ID: 17268407 [Abstract] [Full Text] [Related]
3. Involvement of the sigma1 receptor in the appetitive effects of cocaine. Maurice T, Romieu P. Pharmacopsychiatry; 2004 Nov; 37 Suppl 3():S198-207. PubMed ID: 15547786 [Abstract] [Full Text] [Related]
4. The dopamine uptake inhibitor 3 alpha-[bis(4'-fluorophenyl)metoxy]-tropane reduces cocaine-induced early-gene expression, locomotor activity, and conditioned reward. Velázquez-Sánchez C, Ferragud A, Hernández-Rabaza V, Nácher A, Merino V, Cardá M, Murga J, Canales JJ. Neuropsychopharmacology; 2009 Nov; 34(12):2497-507. PubMed ID: 19606084 [Abstract] [Full Text] [Related]
5. Sigma1 receptor antagonist BD1047 enhances reversal of conditioned place preference from cocaine to social interaction. Fritz M, Klement S, El Rawas R, Saria A, Zernig G. Pharmacology; 2011 Nov; 87(1-2):45-8. PubMed ID: 21196793 [Abstract] [Full Text] [Related]
6. Memantine abolishes the formation of cocaine-induced conditioned place preference possibly via its IL-6-modulating effect in medial prefrontal cortex. Lin KY, Cherng CG, Yang FR, Lin LC, Lu RB, Yu L. Behav Brain Res; 2011 Jun 20; 220(1):126-31. PubMed ID: 21277908 [Abstract] [Full Text] [Related]
7. CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors. Houchi H, Babovic D, Pierrefiche O, Ledent C, Daoust M, Naassila M. Neuropsychopharmacology; 2005 Feb 20; 30(2):339-49. PubMed ID: 15383833 [Abstract] [Full Text] [Related]
8. Effect of memantine and CNQX in the acquisition, expression and reinstatement of cocaine-induced conditioned place preference. Maldonado C, Rodríguez-Arias M, Castillo A, Aguilar MA, Miñarro J. Prog Neuropsychopharmacol Biol Psychiatry; 2007 May 09; 31(4):932-9. PubMed ID: 17395352 [Abstract] [Full Text] [Related]
9. Sigma 1 receptor-related neuroactive steroids modulate cocaine-induced reward. Romieu P, Martin-Fardon R, Bowen WD, Maurice T. J Neurosci; 2003 May 01; 23(9):3572-6. PubMed ID: 12736327 [Abstract] [Full Text] [Related]
10. Influence of sigma-1 receptor modulators on ethanol-induced conditioned place preference in the extinction-reinstatement model. Bhutada PS, Mundhada YR, Ghodki YR, Chaware P, Dixit PV, Jain KS, Umathe SN. Behav Pharmacol; 2012 Feb 01; 23(1):25-33. PubMed ID: 22139605 [Abstract] [Full Text] [Related]
11. Role of accumbens BDNF and TrkB in cocaine-induced psychomotor sensitization, conditioned-place preference, and reinstatement in rats. Bahi A, Boyer F, Chandrasekar V, Dreyer JL. Psychopharmacology (Berl); 2008 Aug 01; 199(2):169-82. PubMed ID: 18551281 [Abstract] [Full Text] [Related]
12. Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors. Hiranita T, Soto PL, Kohut SJ, Kopajtic T, Cao J, Newman AH, Tanda G, Katz JL. J Pharmacol Exp Ther; 2011 Nov 01; 339(2):662-77. PubMed ID: 21859929 [Abstract] [Full Text] [Related]
13. Increased expression of 5-HT6 receptors in the nucleus accumbens blocks the rewarding but not psychomotor activating properties of cocaine. Ferguson SM, Mitchell ES, Neumaier JF. Biol Psychiatry; 2008 Jan 15; 63(2):207-13. PubMed ID: 17631868 [Abstract] [Full Text] [Related]
14. Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists. Achat-Mendes C, Anderson KL, Itzhak Y. Neuropsychopharmacology; 2007 Mar 15; 32(3):531-41. PubMed ID: 16760923 [Abstract] [Full Text] [Related]
15. Effect of the kappa opioid agonist R-84760 on cocaine-induced increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice. Zhang Y, Butelman ER, Schlussman SD, Ho A, Kreek MJ. Psychopharmacology (Berl); 2004 Apr 15; 173(1-2):146-52. PubMed ID: 14712342 [Abstract] [Full Text] [Related]
16. The high affinity dopamine uptake inhibitor, JHW 007, blocks cocaine-induced reward, locomotor stimulation and sensitization. Velázquez-Sánchez C, Ferragud A, Murga J, Cardá M, Canales JJ. Eur Neuropsychopharmacol; 2010 Jul 15; 20(7):501-8. PubMed ID: 20413276 [Abstract] [Full Text] [Related]
17. Dopamine D(3) receptor deletion or blockade attenuates cocaine-induced conditioned place preference in mice. Song R, Zhang HY, Peng XQ, Su RB, Yang RF, Li J, Xi ZX, Gardner EL. Neuropharmacology; 2013 Sep 15; 72():82-7. PubMed ID: 23643749 [Abstract] [Full Text] [Related]
18. CM156, a sigma receptor ligand, reverses cocaine-induced place conditioning and transcriptional responses in the brain. Xu YT, Robson MJ, Szeszel-Fedorowicz W, Patel D, Rooney R, McCurdy CR, Matsumoto RR. Pharmacol Biochem Behav; 2012 Mar 15; 101(1):174-80. PubMed ID: 22234290 [Abstract] [Full Text] [Related]
19. The sigma receptor ligand N-phenylpropyl-N'-(4-methoxyphenethyl)3piperazine (YZ-067) enhances the cocaine conditioned-rewarding properties while inhibiting the development of sensitization of cocaine in mice. Tapia MA, Sage AS, Fullerton EI, Judd JM, Hildebrant PC, Will MJ, Lever SZ, Lever JR, Miller DK. Psychopharmacology (Berl); 2020 Mar 15; 237(3):723-734. PubMed ID: 31822924 [Abstract] [Full Text] [Related]
20. Dopamine beta-hydroxylase knockout mice have alterations in dopamine signaling and are hypersensitive to cocaine. Schank JR, Ventura R, Puglisi-Allegra S, Alcaro A, Cole CD, Liles LC, Seeman P, Weinshenker D. Neuropsychopharmacology; 2006 Oct 15; 31(10):2221-30. PubMed ID: 16395294 [Abstract] [Full Text] [Related] Page: [Next] [New Search]